Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities

Herpes simplex viruses (HSVs) display affinity for cell-surface heparan sulfate proteoglycans with biological relevance in virus entry. This study demonstrates the potential of chemically engineered sulfated xylomannans from Scinaia hatei as antiHSV drug candidate. Particularly, a dimethylformamide...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2015
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01448617_v131_n_p315_Ray
http://hdl.handle.net/20.500.12110/paper_01448617_v131_n_p315_Ray
Aporte de:
id paper:paper_01448617_v131_n_p315_Ray
record_format dspace
spelling paper:paper_01448617_v131_n_p315_Ray2023-06-08T15:12:00Z Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities Antiviral drug candidate Cytotoxicity Polysaccharide engineering Scinaia hatei Bioactivity Cell membranes Cytotoxicity Molecular mass Viruses Anionic polysaccharides Anti-viral drugs Antiviral activities Cell-surface heparan Herpes simplex virus Hydroxyl functionality Molecular entities Scinaia hatei Sulfur compounds Human herpesvirus 1 Human herpesvirus 2 Scinaia Simplexvirus antivirus agent glycoside oligosaccharide sulfate xylomannan animal chemistry Chlorocebus aethiops drug effects Herpes simplex virus 1 infrared spectroscopy isolation and purification molecular weight red alga Vero cell line Animals Antiviral Agents Cercopithecus aethiops Glycosides Herpesvirus 1, Human Molecular Weight Oligosaccharides Rhodophyta Spectroscopy, Fourier Transform Infrared Sulfates Vero Cells Herpes simplex viruses (HSVs) display affinity for cell-surface heparan sulfate proteoglycans with biological relevance in virus entry. This study demonstrates the potential of chemically engineered sulfated xylomannans from Scinaia hatei as antiHSV drug candidate. Particularly, a dimethylformamide -SO<inf>3</inf>/pyridine based procedure has been employed for the generation of anionic polysaccharides. This one-step procedure has the power of providing a spectrum of xylomannans with varying molecular masses (<12-74 kDa), sulfate content (1-50%) and glycosyl composition. Especially, the sulfated xylomannans S1F1 and S2F1 possessed altered activity against HSV-1 and HSV-2 compared to the parental compound (F1) and that too in the absence of drug-induced cytotoxicity. Regarding methodological facet, the directive decoration of hydroxyl functionality with sulfate group plus changes in the molecular mass and sugar composition during isolation by the used reagent opens a door for the production of new molecular entity with altered biological activity from other natural sources. © 2015 Elsevier B.V. All rights reserved. 2015 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01448617_v131_n_p315_Ray http://hdl.handle.net/20.500.12110/paper_01448617_v131_n_p315_Ray
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Antiviral drug candidate
Cytotoxicity
Polysaccharide engineering
Scinaia hatei
Bioactivity
Cell membranes
Cytotoxicity
Molecular mass
Viruses
Anionic polysaccharides
Anti-viral drugs
Antiviral activities
Cell-surface heparan
Herpes simplex virus
Hydroxyl functionality
Molecular entities
Scinaia hatei
Sulfur compounds
Human herpesvirus 1
Human herpesvirus 2
Scinaia
Simplexvirus
antivirus agent
glycoside
oligosaccharide
sulfate
xylomannan
animal
chemistry
Chlorocebus aethiops
drug effects
Herpes simplex virus 1
infrared spectroscopy
isolation and purification
molecular weight
red alga
Vero cell line
Animals
Antiviral Agents
Cercopithecus aethiops
Glycosides
Herpesvirus 1, Human
Molecular Weight
Oligosaccharides
Rhodophyta
Spectroscopy, Fourier Transform Infrared
Sulfates
Vero Cells
spellingShingle Antiviral drug candidate
Cytotoxicity
Polysaccharide engineering
Scinaia hatei
Bioactivity
Cell membranes
Cytotoxicity
Molecular mass
Viruses
Anionic polysaccharides
Anti-viral drugs
Antiviral activities
Cell-surface heparan
Herpes simplex virus
Hydroxyl functionality
Molecular entities
Scinaia hatei
Sulfur compounds
Human herpesvirus 1
Human herpesvirus 2
Scinaia
Simplexvirus
antivirus agent
glycoside
oligosaccharide
sulfate
xylomannan
animal
chemistry
Chlorocebus aethiops
drug effects
Herpes simplex virus 1
infrared spectroscopy
isolation and purification
molecular weight
red alga
Vero cell line
Animals
Antiviral Agents
Cercopithecus aethiops
Glycosides
Herpesvirus 1, Human
Molecular Weight
Oligosaccharides
Rhodophyta
Spectroscopy, Fourier Transform Infrared
Sulfates
Vero Cells
Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities
topic_facet Antiviral drug candidate
Cytotoxicity
Polysaccharide engineering
Scinaia hatei
Bioactivity
Cell membranes
Cytotoxicity
Molecular mass
Viruses
Anionic polysaccharides
Anti-viral drugs
Antiviral activities
Cell-surface heparan
Herpes simplex virus
Hydroxyl functionality
Molecular entities
Scinaia hatei
Sulfur compounds
Human herpesvirus 1
Human herpesvirus 2
Scinaia
Simplexvirus
antivirus agent
glycoside
oligosaccharide
sulfate
xylomannan
animal
chemistry
Chlorocebus aethiops
drug effects
Herpes simplex virus 1
infrared spectroscopy
isolation and purification
molecular weight
red alga
Vero cell line
Animals
Antiviral Agents
Cercopithecus aethiops
Glycosides
Herpesvirus 1, Human
Molecular Weight
Oligosaccharides
Rhodophyta
Spectroscopy, Fourier Transform Infrared
Sulfates
Vero Cells
description Herpes simplex viruses (HSVs) display affinity for cell-surface heparan sulfate proteoglycans with biological relevance in virus entry. This study demonstrates the potential of chemically engineered sulfated xylomannans from Scinaia hatei as antiHSV drug candidate. Particularly, a dimethylformamide -SO<inf>3</inf>/pyridine based procedure has been employed for the generation of anionic polysaccharides. This one-step procedure has the power of providing a spectrum of xylomannans with varying molecular masses (<12-74 kDa), sulfate content (1-50%) and glycosyl composition. Especially, the sulfated xylomannans S1F1 and S2F1 possessed altered activity against HSV-1 and HSV-2 compared to the parental compound (F1) and that too in the absence of drug-induced cytotoxicity. Regarding methodological facet, the directive decoration of hydroxyl functionality with sulfate group plus changes in the molecular mass and sugar composition during isolation by the used reagent opens a door for the production of new molecular entity with altered biological activity from other natural sources. © 2015 Elsevier B.V. All rights reserved.
title Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities
title_short Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities
title_full Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities
title_fullStr Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities
title_full_unstemmed Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities
title_sort additionally sulfated xylomannan sulfates from scinaia hatei and their antiviral activities
publishDate 2015
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01448617_v131_n_p315_Ray
http://hdl.handle.net/20.500.12110/paper_01448617_v131_n_p315_Ray
_version_ 1768546153899491328